WallStreetZenWallStreetZen

NASDAQ: BCYC
Bicycle Therapeutics PLC Earnings & Revenue

BCYC past revenue growth

How has BCYC's revenue growth performed historically?
Company
168.47%
Industry
82.96%
Market
15.15%
BCYC's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
BCYC's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
BCYC's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

BCYC earnings and revenue history

Current Revenue
$41.6M
Current Earnings
-$168.2M
Current Profit Margin
-404.1%

BCYC Return on Equity

Current Company
-49.3%
Current Industry
16.8%
Current Market
28.2%
BCYC's Return on Equity (-49.3%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when BCYC announces earnings.

BCYC Return on Assets

Current Company
-30.1%
Current Industry
3.2%
BCYC is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

BCYC Return on Capital Employed

Current Company
-32.79%
Current Industry
-43.6%
BCYC's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

BCYC vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
BCYC$41.61M-$156.52M-$168.16M+31.18%N/A
PLRX$248.00k-$164.98M-$170.74M-76.83%N/A
PROK$0.00-$26.39M-$35.30MN/AN/A
RLAY$35.33M-$323.65M-$329.12M-83.27%N/A
SPRY$10.00k-$49.63M-$49.70M-95.97%N/A

Bicycle Therapeutics Earnings & Revenue FAQ

What were BCYC's earnings last quarter?

On Invalid Date, Bicycle Therapeutics (NASDAQ: BCYC) reported Q1 2024 earnings per share (EPS) of -$0.62, up 52.31% year over year. Total Bicycle Therapeutics earnings for the quarter were -$26.56 million. In the same quarter last year, Bicycle Therapeutics's earnings per share (EPS) was -$1.30.

If you're new to stock investing, here's how to buy Bicycle Therapeutics stock.

What was BCYC's earnings growth in the past year?

As of Q2 2024, Bicycle Therapeutics's earnings has grown year over year. Bicycle Therapeutics's earnings in the past year totalled -$168.16 million.

What was BCYC's revenue last quarter?

On Invalid Date, Bicycle Therapeutics (NASDAQ: BCYC) reported Q1 2024 revenue of $19.53 million up 298.9% year over year. In the same quarter last year, Bicycle Therapeutics's revenue was $4.90 million.

What was BCYC's revenue growth in the past year?

As of Q2 2024, Bicycle Therapeutics's revenue has grown 168.47% year over year. This is 85.51 percentage points higher than the US Biotechnology industry revenue growth rate of 82.96%. Bicycle Therapeutics's revenue in the past year totalled $41.61 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.